Making Pharmaceuticals UK
Date: October 5-6, 2021
Location: Coventry Building Society Arena, UK
Director of Scientific Services, Catalent
Session Title: Overcoming Key Challenges in Early Oral Formulation Development
Session Date: Wednesday, October 6, 2021
Session Time: 12:55 -13:10 BST
Abstract: Transitioning a molecule from discovery to phase 1 readiness would require a fast and efficient development process that can help deliver the right clinical candidate, best formulation strategy, and an optimal dosage form. The presentation will review details of some established data-driven approaches, including physiologically based pharmacokinetic (PBPK) modeling, parallel formulation screening, and optimal early dosing strategies that will help avoid development pitfalls and de-risk a molecule’s path to clinic.